
Benjamin P. Blumel
Examiner (ID: 14378, Phone: (571)272-4960 , Office: P/1648 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1648, 1671 |
| Total Applications | 1303 |
| Issued Applications | 791 |
| Pending Applications | 138 |
| Abandoned Applications | 405 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16414503
[patent_doc_number] => 10822379
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-11-03
[patent_title] => Molecules that bind to SARS-CoV-2
[patent_app_type] => utility
[patent_app_number] => 15/931939
[patent_app_country] => US
[patent_app_date] => 2020-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 16
[patent_no_of_words] => 35658
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15931939
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/931939 | Molecules that bind to SARS-CoV-2 | May 13, 2020 | Issued |
Array
(
[id] => 17890761
[patent_doc_number] => 11453714
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-27
[patent_title] => Human antibodies to influenza hemagglutinin
[patent_app_type] => utility
[patent_app_number] => 16/870669
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 34477
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 274
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16870669
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/870669 | Human antibodies to influenza hemagglutinin | May 7, 2020 | Issued |
Array
(
[id] => 19389882
[patent_doc_number] => 20240279752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => PROTECTION SEQUENCE, PRIMER, PROBE, COMPOSITION AND KIT FOR STEADY-STATE RAPID DETECTION OF NOVEL CORONAVIRUS, AND USE THEREOF AND METHOD THEREFOR
[patent_app_type] => utility
[patent_app_number] => 18/004410
[patent_app_country] => US
[patent_app_date] => 2020-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7752
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004410
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/004410 | PROTECTION SEQUENCE, PRIMER, PROBE, COMPOSITION AND KIT FOR STEADY-STATE RAPID DETECTION OF NOVEL CORONAVIRUS, AND USE THEREOF AND METHOD THEREFOR | May 5, 2020 | Pending |
Array
(
[id] => 16267421
[patent_doc_number] => 20200268908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => RABIES VACCINE
[patent_app_type] => utility
[patent_app_number] => 16/865107
[patent_app_country] => US
[patent_app_date] => 2020-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31427
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16865107
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/865107 | Rabies vaccine | Apr 30, 2020 | Issued |
Array
(
[id] => 16238631
[patent_doc_number] => 20200255865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => SINGLE CYCLE REPLICATING ADENOVIRUS VECTORS
[patent_app_type] => utility
[patent_app_number] => 16/863705
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4584
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16863705
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/863705 | Single cycle replicating adenovirus vectors | Apr 29, 2020 | Issued |
Array
(
[id] => 17170785
[patent_doc_number] => 20210324455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => In-Vitro Method and Device for Detecting a Target Nucleic Acid
[patent_app_type] => utility
[patent_app_number] => 16/860765
[patent_app_country] => US
[patent_app_date] => 2020-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5584
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16860765
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/860765 | In-Vitro Method and Device for Detecting a Target Nucleic Acid | Apr 27, 2020 | Pending |
Array
(
[id] => 17377063
[patent_doc_number] => 11235052
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-01
[patent_title] => Chikungunya virus RNA vaccines
[patent_app_type] => utility
[patent_app_number] => 16/853973
[patent_app_country] => US
[patent_app_date] => 2020-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 57
[patent_figures_cnt] => 88
[patent_no_of_words] => 91043
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16853973
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/853973 | Chikungunya virus RNA vaccines | Apr 20, 2020 | Issued |
Array
(
[id] => 17489330
[patent_doc_number] => 11278611
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-22
[patent_title] => Zika virus RNA vaccines
[patent_app_type] => utility
[patent_app_number] => 16/850519
[patent_app_country] => US
[patent_app_date] => 2020-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 57
[patent_figures_cnt] => 89
[patent_no_of_words] => 91041
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16850519
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/850519 | Zika virus RNA vaccines | Apr 15, 2020 | Issued |
Array
(
[id] => 17306315
[patent_doc_number] => 11207398
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-28
[patent_title] => Zika virus mRNA vaccines
[patent_app_type] => utility
[patent_app_number] => 16/848318
[patent_app_country] => US
[patent_app_date] => 2020-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4504
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16848318
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/848318 | Zika virus mRNA vaccines | Apr 13, 2020 | Issued |
Array
(
[id] => 17350888
[patent_doc_number] => 11225513
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-18
[patent_title] => Method to improve virus filtration capacity
[patent_app_type] => utility
[patent_app_number] => 16/848564
[patent_app_country] => US
[patent_app_date] => 2020-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 13219
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16848564
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/848564 | Method to improve virus filtration capacity | Apr 13, 2020 | Issued |
Array
(
[id] => 16283975
[patent_doc_number] => 20200277577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => ORF7 DEFICIENT VARICELLA VIRUS, VACCINE COMPRISING THE VIRUS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/847360
[patent_app_country] => US
[patent_app_date] => 2020-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6546
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16847360
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/847360 | ORF7 deficient varicella virus, vaccine comprising the virus and use thereof | Apr 12, 2020 | Issued |
Array
(
[id] => 16359437
[patent_doc_number] => 20200316188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => BROAD AND LONG-LASTING INFLUENZA VACCINE
[patent_app_type] => utility
[patent_app_number] => 16/840723
[patent_app_country] => US
[patent_app_date] => 2020-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15544
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16840723
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/840723 | BROAD AND LONG-LASTING INFLUENZA VACCINE | Apr 5, 2020 | Abandoned |
Array
(
[id] => 17650731
[patent_doc_number] => 11353454
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Methods for detection of flavivirus antibodies
[patent_app_type] => utility
[patent_app_number] => 16/831525
[patent_app_country] => US
[patent_app_date] => 2020-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 73
[patent_figures_cnt] => 102
[patent_no_of_words] => 41443
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16831525
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/831525 | Methods for detection of flavivirus antibodies | Mar 25, 2020 | Issued |
Array
(
[id] => 16596673
[patent_doc_number] => 20210023204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => METHODS FOR PREVENTING DENGUE AND HEPATITIS A
[patent_app_type] => utility
[patent_app_number] => 16/809268
[patent_app_country] => US
[patent_app_date] => 2020-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60320
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16809268
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/809268 | Methods for preventing dengue and hepatitis A | Mar 3, 2020 | Issued |
Array
(
[id] => 17799074
[patent_doc_number] => 11413341
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-16
[patent_title] => Vaccinia viral vectors encoding chimeric virus like particles
[patent_app_type] => utility
[patent_app_number] => 16/796350
[patent_app_country] => US
[patent_app_date] => 2020-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 21817
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16796350
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/796350 | Vaccinia viral vectors encoding chimeric virus like particles | Feb 19, 2020 | Issued |
Array
(
[id] => 18221873
[patent_doc_number] => 20230060867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => STABILIZED 9 AND 10 SEGMENTED INFLUENZA VIRUSES AS A VACCINE PLATFORM AND METHODS OF MAKING AND USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/428921
[patent_app_country] => US
[patent_app_date] => 2020-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20070
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17428921
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/428921 | Stabilized 9 and 10 segmented influenza viruses as a vaccine platform and methods of making and using same | Feb 6, 2020 | Issued |
Array
(
[id] => 17451898
[patent_doc_number] => 11266735
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-08
[patent_title] => Combination vaccine
[patent_app_type] => utility
[patent_app_number] => 16/781781
[patent_app_country] => US
[patent_app_date] => 2020-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 26
[patent_no_of_words] => 34438
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16781781
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/781781 | Combination vaccine | Feb 3, 2020 | Issued |
Array
(
[id] => 19910445
[patent_doc_number] => 12286646
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-29
[patent_title] => Methods for in vitro evolution of constructs derived from viruses
[patent_app_type] => utility
[patent_app_number] => 16/739182
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 24
[patent_no_of_words] => 13320
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16739182
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/739182 | Methods for in vitro evolution of constructs derived from viruses | Jan 9, 2020 | Issued |
Array
(
[id] => 16451081
[patent_doc_number] => 20200360507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => INFLUENZA VACCINE
[patent_app_type] => utility
[patent_app_number] => 16/722437
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42161
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16722437
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/722437 | Influenza vaccine | Dec 19, 2019 | Issued |
Array
(
[id] => 16072991
[patent_doc_number] => 20200190482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => VIRAL VECTOR MANUFACTURE
[patent_app_type] => utility
[patent_app_number] => 16/711184
[patent_app_country] => US
[patent_app_date] => 2019-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26211
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16711184
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/711184 | VIRAL VECTOR MANUFACTURE | Dec 10, 2019 | Abandoned |